SurgiLight files vitiligo laser treatment in US:
This article was originally published in Clinica
Executive Summary
SurgiLight has submitted its EX-308 excimer laser to the US FDA for permission to market the product as a treatment for vitiligo, a skin disorder that leads to the loss of skin pigmentation. The laser is already approved for treating psoriasis. SurgiLight of Orlando, Florida, says that vitiligo is estimated to affect around 1-2% of the world population and around two to four million people in the US.